{
  "ticker": "XLO",
  "year": 2024,
  "quarter": 4,
  "last_updated": "2025-04-19T09:55:23.615356",
  "count": 4,
  "transactions": [
    {
      "id": 223450,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-18",
      "transaction_shares": "1759978",
      "transaction_price": "1.04",
      "transaction_type": "P",
      "shares_after_transaction": "9105451"
    },
    {
      "id": 258719,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-18",
      "transaction_shares": "1759978",
      "transaction_price": "1.04",
      "transaction_type": "P",
      "shares_after_transaction": "9105451"
    },
    {
      "id": 299140,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-18",
      "transaction_shares": "1759978",
      "transaction_price": "1.04",
      "transaction_type": "P",
      "shares_after_transaction": "9105451"
    },
    {
      "id": 344137,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-18",
      "transaction_shares": "1759978",
      "transaction_price": "1.04",
      "transaction_type": "P",
      "shares_after_transaction": "9105451"
    }
  ]
}